<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Med Ther</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Med Ther</journal-id><journal-title-group><journal-title>BMC Complementary Medicine and Therapies</journal-title></journal-title-group><issn pub-type="epub">2662-7671</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7325248</article-id><article-id pub-id-type="publisher-id">2999</article-id><article-id pub-id-type="doi">10.1186/s12906-020-02999-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>Eucalyptus</italic> essential oils inhibit the lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages through reducing MAPK and NF-&#x003ba;B pathways</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ho</surname><given-names>Chen-Lung</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Lan-Hui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Weng</surname><given-names>Yueh-Chun</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hua</surname><given-names>Kuo-Feng</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2968-4138</contrib-id><name><surname>Ju</surname><given-names>Tz-Chuen</given-names></name><address><email>tzchuen@thu.edu.tw</email></address><xref ref-type="aff" rid="Aff7">7</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.410768.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9220 4043</institution-id><institution>Division of Wood Cellulose, </institution><institution>Taiwan Forestry Research Institute, </institution></institution-wrap>Taipei, Taiwan </aff><aff id="Aff2"><label>2</label>Department of Laboratory Medicine, Linsen, Chinese Medicine and Kunming Branch, Taipei City Hospital, Taipei, Taiwan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.260565.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0634 0356</institution-id><institution>Department of Pathology, Tri-Service General Hospital, </institution><institution>National Defense Medical Center, </institution></institution-wrap>Taipei, Taiwan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.412063.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 3626</institution-id><institution>EMA program in College of Bioresources, </institution><institution>National Ilan University, </institution></institution-wrap>Ilan, Taiwan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.412063.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 3626</institution-id><institution>Department of Biotechnology and Animal Science, </institution><institution>National Ilan University, </institution></institution-wrap>Ilan, Taiwan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.254145.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0083 6092</institution-id><institution>Department of Medical Research, China Medical University Hospital, </institution><institution>China Medical University, </institution></institution-wrap>Taichung, Taiwan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.265231.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0532 1428</institution-id><institution>Department of Animal Science and Biotechnology, </institution><institution>Tunghai University, </institution></institution-wrap>No. 1727, Sec. 4, Taiwan Blvd., Xitun Dist, Taichung City, 40704 Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>20</volume><elocation-id>200</elocation-id><history><date date-type="received"><day>11</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1"><italic>Eucalyptus</italic> essential oils have been used in traditional medicine for centuries. It was reported that <italic>Eucalyptus</italic> leaves possess antioxidant and antimicrobial effects. Here, we investigated the anti-inflammatory activity of the essential oils extracted from the leaves of four different <italic>Eucalyptus</italic> species in RAW264.7 macrophages.</p></sec><sec><title>Methods</title><p id="Par2">Lipopolysaccharide (LPS)-activated RAW264.7 macrophages were used to evaluate the anti-inflammatory activity of the leaf essential oils of <italic>Eucalyptus</italic>. The cell survival was quantified by an Alamar Blue assay. Nitric oxide (NO) production was assessed by Griess reaction. TNF-&#x003b1; and IL-6 production were measured by enzyme-linked immunosorbent assay (ELISA). Nuclear factor-&#x003ba;B (NF-&#x003ba;B) transcriptional activity was measured by NF-&#x003ba;B reporter assay. Intracellular protein expression levels were determined by Western blot. The expression levels of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), mitogen-activated protein kinase (MAPK), protein kinase C (PKC) and NF-&#x003ba;B pathway were measured by western blot in LPS-activated RAW 264.7 macrophage.</p></sec><sec><title>Results</title><p id="Par3">The essential oils extracted from <italic>Eucalyptus citriodora</italic> leaf exert the best NO inhibitory activity in LPS-activated RAW264.7 macrophages. The essential oils were fractionated into fractions A-H, and fraction F has been demonstrated to inhibit the expression levels of TNF-&#x003b1;, IL-6, NO, iNOS and COX-2 in LPS-activated RAW264.7 macrophages. Mechanistic analysis revealed that fraction F reduced the phosphorylation levels of ERK1/2, p38, PKC-&#x003b1;, PKC-&#x003b5; and PKC-&#x003b4;, and inhibited the NF-&#x003ba;B transcriptional activity. The chemical composition of Fraction F was determined by GC-MS.</p></sec><sec><title>Conclusions</title><p id="Par4">The discoveries made herein could help develop innovative nonsteroidal anti-inflammatory drugs with minimal side effects and strong efficacy. Clinical trials on these <italic>Eucalyptus</italic> leaf essential oils will help customize and optimize their therapeutic administration.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Anti-inflammation</kwd><kwd><italic>Eucalyptus</italic> essential oils</kwd><kwd>Macrophages</kwd><kwd>Cytokine</kwd><kwd>Lipopolysaccharide</kwd></kwd-group><funding-group><award-group><funding-source><institution>Ministry of Science and Technology of Taiwan </institution></funding-source><award-id>MOST 106-2311-B-029-005</award-id><award-id>MOST 107-2311-B-029-002</award-id><principal-award-recipient><name><surname>Ju</surname><given-names>Tz-Chuen</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par40"><italic>Eucalyptus</italic> trees are in the genus <italic>Eucalyptus</italic> of the <italic>Myrtaceae</italic>. There are &#x0003e;&#x02009;700 <italic>Eucalyptus</italic> tree species worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. They originated in Australia and Indonesia. The wood is used for pulp, fiber, fuel, furniture and construction. The essential oils are distilled from the leaves and used for medicinal purposes. <italic>Eucalyptus</italic> trees grow rapidly and adapt well to their surroundings. They were introduced into Taiwan in the 1980s primarily as sources of pulp for papermaking. <italic>Eucalyptus</italic> essential oils are widely used in traditional cold, fever and bronchitis remedies [<xref ref-type="bibr" rid="CR2">2</xref>]. Vapor inhalation and oral ingestion of <italic>Eucalyptus</italic> essential oils treat suppurative and general respiratory tract infections such as asthma and chronic obstructive pulmonary disease (COPD) [<xref ref-type="bibr" rid="CR3">3</xref>]. Previous research found that <italic>Eucalyptus</italic> essential oils inhibit <italic>Trypanosoma</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. Lemon <italic>Eucalyptus</italic> essential oil has strong efficacy against <italic>Amblyomma cajennense</italic> and <italic>Anocentor nitens</italic> [<xref ref-type="bibr" rid="CR5">5</xref>]. The essential oils in <italic>Eucalyptus</italic> leaves have antiseptic efficacy against <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR6">6</xref>]. Salem et al. proposed that essential oils from <italic>E. citriodora</italic> possesses strong bactericidal and fungicidal activities [<xref ref-type="bibr" rid="CR7">7</xref>]. <italic>Eucalyptus</italic> essential oils are immunoregulatory, anti-inflammatory, antioxidant and analgesic. They also enhance the phagocytic capacity of monocytes and macrophages [<xref ref-type="bibr" rid="CR3">3</xref>]. The essential oils from <italic>E. camaldulensis</italic> kill <italic>Aedes aegypti</italic> and <italic>A. albopictus</italic> larvae [<xref ref-type="bibr" rid="CR1">1</xref>]. <italic>Eucalyptus</italic> essential oils neutralize free radicals and reactive oxygen species (ROS) [<xref ref-type="bibr" rid="CR8">8</xref>]. Essential oils from <italic>E. citriodora</italic>, <italic>E. globulus</italic> and <italic>E. tereticornis</italic> also exert analgesic and anti-inflammatory activity [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par41">Bacterial infections trigger immune responses in the human body and large amounts of proinflammatory substances are released. Moderate inflammatory reactions activate immune cells that kill pathogens and protect the body. However, excessive inflammatory reactions cause rapid cell death and lower blood pressure which results in ischemia, tissue necrosis, organ failure and death. Thus, controlling inflammatory reactions is a medical priority. Inflammatory reactions protect the body against pathogens but may also injure surrounding tissue [<xref ref-type="bibr" rid="CR9">9</xref>]. Whereas mild inflammatory reactions are beneficial and protective, severe inflammation may be destructive as it induces high fever, delirium and sepsis. Early acute inflammatory reactions are generally resolved after healing. However, they may persist and become chronic if they are dysregulated. Chronic inflammation may cause and/or exacerbate atherosclerosis [<xref ref-type="bibr" rid="CR10">10</xref>], diabetes [<xref ref-type="bibr" rid="CR11">11</xref>], aging [<xref ref-type="bibr" rid="CR12">12</xref>], neurodegeneration [<xref ref-type="bibr" rid="CR13">13</xref>], and cancer [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par42">Inflammation is therapeutically controlled mainly by steroidal and nonsteroidal anti-inflammatory drugs (NSAIDs). The former has numerous serious side effects and may induce and/or exacerbate hypertension, diabetes, glaucoma, hypertension, dermal atrophy, myopathy, hirsutism, insomnia, depression and mental illness. In contrast, the side effects of NSAIDs are relatively minor and may include gastrointestinal distress or inflammation. In severe cases, NSAIDs may cause GI perforation, peptic ulcers and hemorrhage. Current research has focused on the discovery of natural nonsteroidal anti-inflammatory fractions with minimal side effects and yet maximal efficacy. In the present study, an in vitro cell culture model was used to examine the influences of <italic>Eucalyptus</italic> essential oils on inflammatory reactions in macrophages. Other objectives were to identify the mutually interacting signal transduction pathways involved in these inflammatory reactions and determine whether <italic>Eucalyptus</italic> essential oils could mitigate the inflammatory response by modulating these biomolecular mechanisms.</p><p id="Par43"><italic>Eucalyptus</italic> essential oils have been used in traditional medical treatments for centuries. They have been extensively studied and are valued for their comparatively low toxicity and broad-spectrum antiseptic activity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Here, we examined the anti-inflammatory activity of the essential oils extracted by water distillation from the leaves of <italic>E. urophylla</italic>, <italic>E. grandis</italic>, <italic>E. camaldulensis</italic> and <italic>E. citriodora</italic>. Lipopolysaccharides (LPS) were applied to RAW264.7 murine macrophages to trigger inflammatory reactions. We first screened the four types of <italic>Eucalyptus</italic> essential oils based on their inhibition of nitric oxide (NO) generation. The most active essential oil will be subjected to chromatographic analysis. Next, we tested the anti-inflammatory activity and elucidate the mechanisms by which they suppress the inflammatory response.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Plant materials</title><p id="Par44">Fresh leaves of <italic>Eucalyptus urophylla</italic>, <italic>Eucalyptus grandis</italic> and <italic>Eucalyptus camaldulensis</italic> were collected in August 2017 from the Kukeng Experimental Plantation of the Taiwan Forestry Research Institute (TFRI) in south-central Taiwan (Yunlin County, elevation 100&#x02009;m, N 23&#x000b0; 62&#x02032; 58&#x002dd;, 120&#x000b0; 57&#x02032; 20&#x002dd;), while fresh leaves of <italic>Eucalyptus citriodora</italic> were collected in August 2019 from the Lienhwachih Research Center, TFRI in central Taiwan (Nantou County, elevation 500&#x02009;m, N 23&#x000b0; 91&#x02032; 75&#x002dd;, 120&#x000b0; 88&#x02032; 52&#x002dd;). The samples were compared with specimen No. E-0032, E-0033, E-0034 and E-0035 from the herbarium of National Chung Hsing University (NCHU) and were positively identified by Prof. Yen-Hsueh Tseng of NCHU. The voucher specimen (CLH-068, CLH-069, CLH-070 and CLH-071) were deposited in the NCHU herbarium. The collected leaves were immediately shipped to our Taipei headquarters, and the essential oils were extracted for subsequent analyses.</p></sec><sec id="Sec4"><title>Extraction of the leaf essential oils</title><p id="Par45">A sample of 1&#x02009;kg of fresh leaves from each species was placed in a round-bottomed flask, and 3&#x02009;L of distilled water was added. After 8&#x02009;h of steam distillation, the oil layers had separated from the water layers and were collected, and anhydrous sodium sulfate was added to eliminate the water. We repeated the isolation procedure for 4 times and combined the leaf essential oil for further fractionation. Yields of the essential oils were determined and the oils were stored in specimen bottles. Yields of leaf essential oils of <italic>E. urophylla</italic>, <italic>E. grandis</italic>, <italic>E. camaldulensis</italic> and <italic>E. citriodora</italic> were 3.18&#x02009;&#x000b1;&#x02009;0.05, 2.98&#x02009;&#x000b1;&#x02009;0.06, 3.58&#x02009;&#x000b1;&#x02009;0.07, and 1.98&#x02009;&#x000b1;&#x02009;0.08&#x02009;ml/100&#x02009;g, respectively.</p></sec><sec id="Sec5"><title>Fractionation of the leaf essential oil of <italic>E. citriodora</italic></title><p id="Par46">Fifty grams of <italic>E. citriodora</italic> leaf oil was mixed with 100&#x02009;g silica gel (Merck 7734, Merck Co., Germany), separated on a silica gel open column (1000&#x02009;g, 85&#x02009;mm i.d., 850&#x02009;mm length), and then eluted with a step gradient of n-hexane and ethyl acetate that ranged from n-hexane/ethyl acetate&#x02009;=&#x02009;100:0&#x02013;0:100. The fractions were collected by thin layer chromatography (TLC) and visualized at UV 254&#x02009;nm and UV 366&#x02009;nm, with iodine vapor and 1% vanillin/H<sub>2</sub>SO<sub>4</sub>. The band fractions from the leaf oil that contained the same compounds were combined to produce 8 sub-fractions: fractions A (5.3%), B (7.6%), C (11.5%), D (9.8%), E (10.2%), F (35.2%), G (18.1%), and H (2.3%).</p></sec><sec id="Sec6"><title>Gas chromatography-mass spectrometry (GC-MS) analysis of fractions F and G</title><p id="Par47">A Hewlett-Packard HP 6890 gas chromatograph equipped with a DB-5 fused silica capillary column (30&#x02009;m&#x02009;&#x000d7;&#x02009;0.25&#x02009;mm&#x02009;&#x000d7;&#x02009;0.25&#x02009;&#x003bc;m film thickness, J&#x00026;W Scientific) and a FID detector were used for the quantitative determination of the chemical compositions of fractions F and G. Samples were incubated in an oven at 50&#x02009;&#x000b0;C for 2&#x02009;min, and then the temperature incrementally increased to 250&#x02009;&#x000b0;C at 5&#x02009;&#x000b0;C/min. The injection temperature was 270&#x02009;&#x000b0;C. The carrier gas was helium and had a 1&#x02009;ml/min flow rate. The detector temperature was 250&#x02009;&#x000b0;C, with a split ratio of 1:10. The injection volume was 1&#x02009;&#x003bc;l. Identification of the oil components was based on their retention indices and mass spectra obtained from GC-MS analysis on a Hewlett-Packard HP 6890/HP5973 equipped with a DB-5 fused silica capillary column (30&#x02009;m&#x02009;&#x000d7;&#x02009;0.25&#x02009;mm&#x02009;&#x000d7;&#x02009;0.25&#x02009;&#x003bc;m film thickness, J&#x00026;W Scientific). The MS reuslts were obtained in full scan mode with a 0.3&#x02009;s scan time and a mass range of <italic>m/z</italic> 30&#x02013;500 in the EI mode at 70&#x02009;eV. All data are presented as the average of experiments performed in triplicate. Identification of the chemical compositions of fractions F and G was based on comparisons of Kovats index (KI), retention times (RT), and mass spectra with those obtained from authentic standards and/or the NIST and Wiley libraries spectra, and literature, respectively. The F and G fractions were identified using their Kov&#x000e1;ts retention indices calculated for all volatile constituents using a homologous series of n-alkanes C9-C23 on DB-5MS column, and comparing sample mass spectra with those obtained from authentic standards and/or the NIST and Wiley libraries spectra, and the literature [<xref ref-type="bibr" rid="CR15">15</xref>].</p></sec><sec id="Sec7"><title>Materials</title><p id="Par48">Antibodies against PKC-&#x003b1;, PKC-&#x003b5; and PKC-&#x003b4;, COX2, p-IKK-&#x003b1; and anti-p-I&#x003ba;B-&#x003b1; were procured from Santa Cruz Biotechnology (Dallas, TX). Antibodies against p-ERK1/2, p-JNK1/2 and p-p38 were purchased from Cell Signaling Technology (Danvers, MA). Antibodies against iNOS and &#x003b2;-actin, lysis buffer and polyvinylidene fluoride (PVDF) membrane were purchased from EMD Millipore (Bedford, MA). LPS (<italic>Escherichia coli</italic> O111:B4) and protease/phosphatase inhibitor cocktail were purchased from Sigma-Aldrich (St. Louis, MO). Enzyme-linked immunosorbent assay (ELISA) kits and enhanced chemiluminescence (ECL) reagents were purchased from Thermo Fisher Scientific (Waltham, MA). RPMI 1640 was purchased from Gibco Laboratories (Grand Island, NY, USA). Fetal bovine serum (FBS) was purchased from Biological Industries Ltd. (Kibbutz Beit Ha-emek, Israel). L-glutamine was purchased from Life Technologies (Carlsbad, CA, USA). Alamar Blue assay kit was purchased from AbD Serotec (Oxford, UK). QUANTI-Blue medium was purchased from InvivoGen (San Diego, CA).</p></sec><sec id="Sec8"><title>Cell cultures</title><p id="Par49">RAW264.7 macrophage were purchased from the American Type Culture Collection (Rockville, MD). RAW-Blue macrophages were purchased from InvivoGen (San Diego, CA). All cells were propagated in RPMI 1640 supplemented with 10% (v/v) heat-inactivated FBS and 2&#x02009;mM&#x02009;<italic>L</italic>-glutamine at 37&#x02009;&#x000b0;C in a 5% CO<sub>2</sub> incubator [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec9"><title>Cell viability assay</title><p id="Par50">Cell death was quantified by the MTT reduction assay.</p><p id="Par51">Cell viability was quantified by the Alamar Blue assay. Breifly, RAW264.7 macrophages were incubated with or without tested sample for 24&#x02009;h. Alamar Blue reagent (10&#x02009;&#x003bc;l) was added into the culture medium and incubated at 37&#x02009;&#x000b0;C in a 5% CO<sub>2</sub> incubator for 2&#x02013;3&#x02009;h. Fluorescence was detected with a fluorescence microplate reader (excitation/emission: 570&#x02009;nm/600&#x02009;nm; OPTImax tunable plate reader; Molecular Devices, Sunnyvale, CA, USA).</p></sec><sec id="Sec10"><title>NO production assay</title><p id="Par52">RAW264.7 macrophages were incubated for 0.5&#x02009;h with tested samples, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. NO levels in the culture medium were measured by the Griess reaction as described previously [<xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec11"><title>Western blot analysis</title><p id="Par53">Western blot was performed as described previously [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Briefly, protein was extracted with a protease and phosphatase inhibitor cocktail containing lysis buffer. The lysates were electrophoretically fractionated through 10% SDS-polyacrylamide gel and then electrotransferred onto PVDF membranes. The membranes were incubated for 1&#x02009;h at room temperature in 5% (v/v) nonfat milk in phosphate-buffered saline (PBS) with 0.1% (v/v) Tween-20). The primary antibodies were applied to the blots and incubated for 2&#x02009;h at room temperature, followed by secondary antibody for 1&#x02009;h at room temperature. The immunoreactive signals were detected with ECL reagents.</p></sec><sec id="Sec12"><title>NF-&#x003ba;B reporter assay</title><p id="Par54">The NF-&#x003ba;B reporter assay was conducted as described previously [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Briefly, RAW-Blue cells (10<sup>5</sup> cells per 0.5&#x02009;ml medium) were treated for 0.5&#x02009;h with 12.5&#x02009;&#x003bc;g/ml, 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml or 100&#x02009;&#x003bc;g/ml Fraction F, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. The harvested medium (20&#x02009;&#x003bc;l) was mixed with 200&#x02009;&#x003bc;l QUANTI-Blue medium in 96-well plates and incubated at 37&#x02009;&#x000b0;C for 2&#x02009;h. SEAP activity was measured at 655&#x02009;nm in an ELISA microplate reader (Bio-Tek Instruments, Winooski, VT, USA).</p></sec><sec id="Sec13"><title>ELISA assay</title><p id="Par55">RAW264.7 macrophages (10<sup>5</sup> cells per 0.5&#x02009;ml medium) were treated for 0.5&#x02009;h with tested sample, followed by incubation with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. The levels of TNF-&#x003b1; and IL-6 in the culture medium were measured by ELISA according to the manufacturer&#x02019;s protocol. Briefly, the 96-well microplates were coated overnight with anti-TNF-&#x003b1; or anti-IL-6 antibody, blocked with 1% (v/v) bovine serum albumin (BSA) in PBS, and washed repeatedly. Samples or standards (100&#x02009;&#x003bc;l) were added to the microplates, incubated at room temperature for 2&#x02009;h, washed repeatedly, incubated for 2&#x02009;h with biotin-conjugated detection antibody, and incubated for 30&#x02009;min with 100&#x02009;&#x003bc;l streptavidin-horseradish peroxidase (HRP) plus substrate for signal development. Then 100&#x02009;&#x003bc;l stop solution was added to each well and the OD<sub>450</sub> were measured in an ELISA microplate reader (Bio-Tek Instruments, Winooski, VT, USA) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec14"><title>Statistical analysis</title><p id="Par56">Data were expressed as means &#x000b1; standard deviation (SD) of triplicate samples. Each experiment was repeated at least three times to confirm reproducibility. Multiple groups were analyzed with one-way analysis of variance (ANOVA), followed by a post hoc Student-Newman-Keuls test. Differences among treatment means were considered statistically significant when <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec id="Sec15"><title>Result</title><sec id="Sec16"><title>Effects of leaf essential oils from different Eucalyptus species on NO generation and cell viability</title><p id="Par57">NO shows a crucial role in LPS-induced inflammatory reactions in macrophages. Thus, we evaluated the effect of the leaf essential oils extracted from <italic>E. citriodora, E. grandis, E. urophylla</italic> and <italic>E. camaldulensis</italic> on NO production in LPS-activated macrophages. RAW264.7 macrophages were incubated with or without 25, 50 or 100&#x02009;&#x003bc;g/ml essential oils for 0.5&#x02009;h followed by LPS stimulation for 24&#x02009;h (each group containing 0.1% DMSO in the cultural medium). We found that leaf essential oils from <italic>E. grandis</italic> and <italic>E. citriodora</italic> reduced the NO production in a dose dependent manner, while <italic>E. citriodora</italic> was potent than <italic>E. grandis</italic>. However, LPS-induced NO production was not affected by leaf essential oils from <italic>E. urophylla</italic> and <italic>E. camaldulensis</italic> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). We next investigated the influences of four leaf essential oils on the cell viability by Alamar Blue assay. RAW264.7 macrophages were incubated with or without 25, 50 or 100&#x02009;&#x003bc;g/ml essential oils for 24&#x02009;h. We found that leaf essential oils from <italic>E. citriodora</italic> and <italic>E. grandis</italic> reduced RAW264.7 macrophages viability in a dose dependent manner; however, the viability was not significantly reduced by the leaf essential oils from <italic>E. urophylla</italic> and <italic>E. camaldulensis</italic> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Effects of leaf essential oils from different <italic>Eucalyptus</italic> species on NO generation and cell viability. <bold>a</bold> RAW264.7 macrophages were incubated for 0.5&#x02009;h with 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml, 100&#x02009;&#x003bc;g/ml or 200&#x02009;&#x003bc;g/ml <italic>Eucalyptus</italic> essential oils, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. NO levels in the culture medium were measured by the Griess reaction. <bold>b</bold> RAW264.7 macrophages were incubated with or without 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml, 100&#x02009;&#x003bc;g/ml or 200&#x02009;&#x003bc;g/ml leaf <italic>Eucalyptus</italic> essential oils for 24&#x02009;h. Cell viability was determined by the Alamar Blue assay. Data are expressed as means &#x000b1; SD for three independent experiments. * <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 compared to LPS alone. (<italic>n</italic>&#x02009;=&#x02009;3)</p></caption><graphic xlink:href="12906_2020_2999_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec17"><title>Subfractions of <italic>E. citriodora</italic> leaf essential oils inhibited NO generation</title><p id="Par58">As the leaf essential oils from <italic>E. citriodora</italic> had the most potent NO inhibitory activity in LPS-activated RAW264.7 macrophages, the essential oils were fractionated into Fractions A- H. We found that Fractions D, E, F, G and H significantly reduced NO generation to 63, 62, 42, 37 and 0.1%, respectively, in LPS-activated RAW264.7 macrophages (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). Although fraction H exerts the best NO inhibitory activity, the yield of the fraction H (2.3%) is too low to test its biological activity. Therefore, fractions D, E, F and G were selected for further investigation. The NO inhibitory activity of Fractions D, E, F and G were confirmed in a dose response study, and Fractions F and G exert better NO inhibitory activity than Fractions D and E (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). In addition, Fractions F and G did not affect the cell viability at the concentration below 400&#x02009;&#x003bc;g/ml (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). These results indicated that Fractions F and G inhibited NO production was not due to the cytotoxicity. Furthermore, the chemical composition of Fractions F and G was analyzed by GC-MS, and the major compound in Fractions F and G was 4-methylsyringol (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Subfractions of <italic>E. citriodora</italic> leaf essential oils inhibited NO generation. (<bold>a</bold>) RAW264.7 macrophages were treated for 0.5&#x02009;h with 100&#x02009;&#x003bc;g/ml Fractions A, B, C, D, E, F, G and H, followed by incubation with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. NO production in the culture medium was measured by the Griess reaction. <bold>b</bold> RAW264.7 macrophages were treated for 0.5&#x02009;h with 12.5&#x02009;&#x003bc;g/ml, 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml or 100&#x02009;&#x003bc;g/ml Fractions D, E, F or G, followed by incubation with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. NO production in the culture medium was measured by the Griess reaction. <bold>c</bold> RAW264.7 macrophages were incubated for 24&#x02009;h with or without Fractions F and G. Cell viability was measured by the Alamar Blue assay. Data are expressed as means &#x000b1; SD of three independent experiments. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 compared to LPS alone. (<italic>n</italic>&#x02009;=&#x02009;3)</p></caption><graphic xlink:href="12906_2020_2999_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Chemical composition of Fractions F and G</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Compound ID</th><th rowspan="2">Kov&#x000e1;ts retention<break/>indices<sup>a</sup></th><th rowspan="2">Kov&#x000e1;ts retention<break/>indices<sup>b</sup></th><th colspan="2">Concentration (%)</th><th rowspan="2">Identification<sup>c</sup></th></tr><tr><th>Fraction F</th><th>Fraction G</th></tr></thead><tbody><tr><td>Menthol</td><td>1171</td><td>1172</td><td>4.6</td><td>17.6</td><td>MS, KI, ST</td></tr><tr><td>4-hydroxy-Benzenemethanol</td><td>1337</td><td>1337</td><td>24.4</td><td>2.2</td><td>MS, KI, ST</td></tr><tr><td>Citronellic acid</td><td>1313</td><td>1311</td><td>12.7</td><td>2.4</td><td>MS, KI, ST</td></tr><tr><td>4-Methylsyringol</td><td>1449</td><td>1451</td><td>41.3</td><td>25.7</td><td>MS, KI, ST</td></tr><tr><td><italic>trans, cis</italic>-Iridolactone</td><td>1446</td><td>1446</td><td>7.6</td><td>- <sup>d</sup></td><td>MS, KI</td></tr><tr><td>14-hydroxy-&#x003b1;-Humulene</td><td>1714</td><td>1714</td><td>&#x02013;</td><td>17.5</td><td>MS, KI</td></tr><tr><td>Manool</td><td>2057</td><td>2057</td><td>1.8</td><td>0.8</td><td>MS, KI, ST</td></tr><tr><td>2-Phenyl ethyl anthranilate</td><td>2126</td><td>2127</td><td>2.2</td><td>0.9</td><td>MS, KI</td></tr><tr><td>Citronellyl anthranilate</td><td>2180</td><td>2181</td><td>1.1</td><td>0.5</td><td>MS, KI, ST</td></tr><tr><td>Geranyl anthranilate</td><td>2217</td><td>2215</td><td>1.1</td><td>0.6</td><td>MS, KI, ST</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Kov&#x000e1;ts retention indices on a DB-5 column with reference to n-alkanes [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p><sup>b</sup> Kov&#x000e1;ts retention indices, experimental: n-alkanes (C9-C24) were used as reference points in the calculation of relative retention indices.</p><p><sup>c</sup> MS, NIST and Wiley library spectra and the literature; KI, Kovats index; ST, authentic standard compounds.</p><p><sup>d</sup> Not detected</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec18"><title>Fraction F inhibited proinflammatory mediators</title><p id="Par59">Although Fractions F and G showed similar NO inhibitory activity, the yield of Fraction F (35.2%) was better than Fraction G (18.1%). Therefore, Fraction F was selected for further evaluation. We found that Fraction F at 12.5, 25 and 50&#x02009;&#x003bc;g/ml reduced the expression levels of IL-6 to 55, 15 and 55%, respectively, in LPS-activated RAW264.7 macrophages (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). Fraction F at 12.5, 25, 50 and 100&#x02009;&#x003bc;g/ml reduced the expression levels of TNF-&#x003b1; to 97, 55, 48 and 53%, respectively, in LPS-activated RAW264.7 macrophages (Fig. <xref rid="Fig3" ref-type="fig">3</xref>b). In addition, Fraction F also reduced the expression levels of COX-2 and iNOS in LPS-activated RAW264.7 macrophages (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Fraction F inhibited proinflammatory mediators. RAW264.7 macrophages were treated for 0.5&#x02009;h with 12.5&#x02009;&#x003bc;g/ml 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml or 100&#x02009;&#x003bc;g/ml Fraction F, followed by incubation with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. The levels of IL-6 (<bold>a</bold>) and TNF-&#x003b1; (<bold>b</bold>) in the culture media were determined by ELISA. The expression levels of COX-2 and iNOS in the cell lysates were measured by Western blot (<bold>c</bold>). Western blot results are representative of three different experiments. ELISA data are presented as means &#x000b1; SD of three independent experiments. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 compared to LPS alone. (<italic>n</italic>&#x02009;=&#x02009;3)</p></caption><graphic xlink:href="12906_2020_2999_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec19"><title>Fraction F reduced NF-&#x003ba;B activation</title><p id="Par60">The transcription factor NF-&#x003ba;B plays a pivotal role in inflammation [<xref ref-type="bibr" rid="CR18">18</xref>]. NF-&#x003ba;B inhibition suppresses NO generation and cytokine secretion in LPS-challenged macrophages [<xref ref-type="bibr" rid="CR19">19</xref>]. Using NF-&#x003ba;B reporter cells (RAW-Blue macrophages), we found that NF-&#x003ba;B transcriptional activity was reduced to 78, 69, 65 and 55% by Fraction F at 12.5, 25, 50 and 100&#x02009;&#x003bc;g/ml, respectively, in LPS-activated macrophages (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). To confirm the NF-&#x003ba;B inhibitory activity of Fraction F, the effect of Fraction F on the phosphorylation levels of IKK-&#x003b1; and I&#x003ba;B-&#x003b1; in LPS-activated RAW264.7 macrophages was investigated [<xref ref-type="bibr" rid="CR20">20</xref>]. We found that Fraction F inhibited the phosphorylation levels of IKK-&#x003b1; and I&#x003ba;B-&#x003b1; in LPS-activated RAW264.7 macrophages (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b).
<fig id="Fig4"><label>Fig. 4</label><caption><p>Fraction F reduced NF-&#x003ba;B activation. <bold>a</bold> RAW-Blue cells were treated for 0.5&#x02009;h with 12.5&#x02009;&#x003bc;g/ml, 25&#x02009;&#x003bc;g/ml, 50&#x02009;&#x003bc;g/ml or 100&#x02009;&#x003bc;g/ml Fraction F, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 24&#x02009;h. NF-&#x003ba;B transcriptional activity were measured by NF-&#x003ba;B reporter assay. <bold>b</bold> RAW264.7 macrophages were treated with 25&#x02009;&#x003bc;g/ml Fraction F, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 0&#x02013;60&#x02009;min. The phosphorylation levels of IKK-&#x003b1; and I-&#x003ba;B-&#x003b1; in the cell lysates were assayed by Western blot. NF-&#x003ba;B transcriptional activity are expressed as means &#x000b1; SD of three independent experiments. Western blot results are representative of three different experiments. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 compared to LPS alone</p></caption><graphic xlink:href="12906_2020_2999_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec20"><title>Fraction F reduced the phosphorylation levels of MAPK and PKC</title><p id="Par61">It has been demonstrated that LPS increased the expression levels of inflammatory mediators via the MAPK and PKC signaling pathways in macrophages [<xref ref-type="bibr" rid="CR19">19</xref>]. We examined the effect of Fraction F on the phosphorylation levels of MAPK and PKC in LPS-activated macrophages. LPS increased the phosphorylation levels of ERK1/2, JNK1/2 and p38, and these effect were slightly reduced by Fraction F (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). In addition, LPS increased the phosphorylation levels of PKC-&#x003b1;, PKC-&#x003b4;, and PKC-&#x003b5;, and these effect were significantly reduced by Fraction F (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Fraction F reduced the phosphorylation levels of MAPK and PKC. RAW264.7 macrophages were treated with 25&#x02009;&#x003bc;g/ml Fraction F, followed by incubated with or without 1&#x02009;&#x003bc;g/ml LPS for 0&#x02013;60&#x02009;min. The phosphorylation levels of ERK1/2, JNK1/2 and p38 (<bold>a</bold>), and phosphorylation levels of PKC-&#x003b1;, PKC-&#x003b5; and PKC-&#x003b4; (<bold>b</bold>) in the cell lysates were assayed by Western blot</p></caption><graphic xlink:href="12906_2020_2999_Fig5_HTML" id="MO5"/></fig></p></sec></sec><sec id="Sec21"><title>Discussion</title><p id="Par62">Inflammation is therapeutically controlled mainly by steroidal and nonsteroidal anti-inflammatory drugs. However, both cause several serious side effects. Current research has focused on the discovery of natural nonsteroidal anti-inflammatory drugs with strong therapeutic efficacy that induce minimal adverse reactions. In this study, of the four <italic>Eucalyptus</italic> species whose leaf essential oils we tested and compared, those from <italic>E. citriodora</italic> most effectively reduced the NO production induced by LPS in murine RAW264.7 macrophages. However, using a cell viability assay we found that the leaf essential oils of <italic>E. citriodora</italic> was toxic to the RAW264.7. To remove the toxic ingredients in the leaf essential oils of <italic>E. citriodora</italic>, the leaf essential oils were fractionated into Fractions A-H by a silica gel column. We found that Fractions F and G keep the anti-inflammatory activity and were not toxic to the Raw264.7 macrophages. When inflammation occurs, monocytes are attracted to chemokines, enter the lesion, and transformed into macrophages that undergo phagocytosis and release proinflammatory cytokines such as IL-6 and TNF-&#x003b1;. It has been demonstrated that LPS induces proinflammatory cytokines through ERK1/2, JNK1/2 and p38 in macrophages [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. In addition, LPS-mediated PKC activation induces the downstream signaling pathways such as MAPK [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>] or NF-&#x003ba;B [<xref ref-type="bibr" rid="CR25">25</xref>], that regulate the expression of IL-1&#x003b2;, IL-6,and TNF-&#x003b1; in macrophages. Here, Fraction F inhibited the phosphorylation levels of ERK1/2, p38, PKC-&#x003b1;, PKC-&#x003b5; and PKC-&#x003b4; as well as suppressed NF-&#x003ba;B activation. However, Fraction F did not suppress JNK1/2 phosphorylation. These results suggest that Fraction F attenuated the inflammatory response in LPS-activated macrophages partially through inhibiting the activation of ERK1/2, p38, PKC-&#x003b1;, PKC-&#x003b5;, and PKC-&#x003b4; and NF-&#x003ba;B.</p><p id="Par63">Notably, although Fraction F inhibited LPS-induced IL-6 secretion at 12.5 and 25&#x02009;&#x003bc;g/ml; the IL-6 inhibitory activity was loss at higher concentration 50 and 100&#x02009;&#x003bc;g/ml (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a). The contradictory effect of Fraction F in IL-6 secretion may due to the complicated chemical composition. Chemical composition analysis showed that Fraction F contained 9 compounds: 4-methylsyringol (41.3%), 4-hydroxyl-Benzenemethanol (24.4%), Citronellic acid (12.7%), <italic>trans, cis</italic>-Iridolactone (7.6%), Menthol (4.6%), 2-Phenyl ethyl anthranilate (2.2%), Manool (1.8%), Citronellyl anthranilate (1.1%) and Citronellyl tiglate (1.1%) (Table <xref rid="Tab1" ref-type="table">1</xref>). Although 4-methylsyringol, 4-hydroxyl-Benzenemethanol and Citronellic acid were the major compounds in Fraction F, there were no biological activity reported yet for these three compounds. Menthol is the fourth most abundant compound in Fraction F, and it has been reported to exert anti-inflammatory activity by suppressing the production of LTB<sub>4</sub>, PGE<sub>2</sub> and IL-1&#x003b2; in LPS-activated human monocytes [<xref ref-type="bibr" rid="CR26">26</xref>]. In addition, Shahid et al. demonstrated that the level of urinary menthol was significantly reduced in interstitial cystitis patients compared to healthy controls [<xref ref-type="bibr" rid="CR27">27</xref>]. Menthol inhibited the expression levels of TNF-&#x003b1;, IL-6, IL-1&#x003b2; and CCL3 in LPS-activated RAW264.7 macrophages through reducing the activation of AKT and NF-&#x003ba;B [<xref ref-type="bibr" rid="CR27">27</xref>]. These results suggest that Menthol (4.6% in fraction F) should be one of the bioactive compound in fraction F that response for the anti-inflammatory activity; however, we cannot rule out the possibility that the anti-inflammatory activity of fraction F was resulted from the synergistic effect between essential oil components.</p><p id="Par64">The biological functions of <italic>Eucalyptus</italic> leaf essential oils have been extensively investigated, including antimicrobial, antiviral, antidiabetic, antioxidant, antitumor and anti-inflammatory activities [<xref ref-type="bibr" rid="CR28">28</xref>]. It has been demonstrated that <italic>E. citriodora</italic> essential oil exerts the anti-inflammatory and analgesic effects on formol-induced edema and acetic acid-induced abdominal cramps in Wistar rats, and the major compound of the <italic>E. citriodora</italic> essential oil is citronellal [<xref ref-type="bibr" rid="CR29">29</xref>]. Juergens et al. demonstrated that 1,8-cineole, isolated from <italic>Eucalyptus</italic> essential oil, inhibits the production of TNF-&#x003b1;, IL-1&#x003b2;, leukotriene B4 and thromboxane B2 in LPS-activated human blood monocytes [<xref ref-type="bibr" rid="CR30">30</xref>]. In addition, <italic>E. globulus</italic> oil reduces LPS-induced chronic bronchitis and mucin hypersecretion in rats; however, the active compound was not identified yet [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par65">Based on the cell viability assay, Fraction F was non-toxic to the RAW264.7 macrophages under the experimental condition (12.5&#x02013;400&#x02009;&#x003bc;g/ml). However, Manool, a minor compound in the Fraction F, has been reported to exhibit higher cytotoxic activity against human cervical adenocarcinoma HeLa cells (IC50&#x02009;=&#x02009;6.7&#x02009;&#x000b1;&#x02009;1.1&#x02009;&#x003bc;g/ml) and human glioblastoma U343 cells (IC50&#x02009;=&#x02009;6.7&#x02009;&#x000b1;&#x02009;1.2&#x02009;&#x003bc;g/ml) than for the normal Chinese hamster lung fibroblasts V79 cells (IC50&#x02009;=&#x02009;49.3&#x02009;&#x000b1;&#x02009;3.3&#x02009;&#x003bc;g/ml) [<xref ref-type="bibr" rid="CR32">32</xref>]. Although Manool in Fraction F only 1.8%, the possible toxic effect of Fraction F should be further investigation. In addition, the anti-inflammatory activity of Fraction F in vivo, and the optimization of the administration routes, dosages and application intervals of Fraction F in animal study need further investigation.</p></sec><sec id="Sec22"><title>Conclusions</title><p id="Par66">Essential oils extracted from <italic>Eucalyptus</italic> leaves have antioxidant, antimicrobial, immunoregulatory, analgesic and anti-inflammatory properties. While conventional NSAIDs cause fewer serious side effects than their steroidal counterparts, they may nonetheless induce GI bleeding, distress, inflammation and ulceration in many patients, thereby reducing therapeutic compliance and treatment efficacy [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>]. Here, we investigated the anti-inflammatory activity of the leaf essential oils from four <italic>Eucalyptus</italic> tree species in LPS-activated RAW264.7 macrophage. We demonstrated that the leaf essential oils from <italic>E. citriodora</italic> exert best NO inhibitory activity than other species. We further demonstrated that the Fraction F of <italic>E. citriodora</italic> leaf essential oils inhibited the expression levels of TNF-&#x003b1;, IL-6, NO, iNOS and COX-2 through reducing PKC/NF-&#x003ba;B and ERK1/2/p38 in the LPS-activated RAW264.7 macrophages (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). These results suggested that leaf essential oils from <italic>E. citriodora</italic> can be developed as a anti-inflammatory agent in the future.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Overview of the putative mechanisms by which <italic>E. citriodora</italic> leaf essential oils attenuated the inflammatory response in macrophage. <italic>E. citriodora</italic> leaf essential oils inhibit LPS-induced inflammatory response in RAW264.7 macrophages by reducing the ERK1/2/p38 and PKC/NF-&#x003ba;B signaling pathways</p></caption><graphic xlink:href="12906_2020_2999_Fig6_HTML" id="MO6"/></fig></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA</term><def><p id="Par5">Analysis of variance</p></def></def-item><def-item><term>BSA</term><def><p id="Par6">Bovine serum albumin</p></def></def-item><def-item><term>CC</term><def><p id="Par7">Column chromatography</p></def></def-item><def-item><term>COPD</term><def><p id="Par8">Chronic obstructive pulmonary disease</p></def></def-item><def-item><term>COX2</term><def><p id="Par9">Cyclooxygenase II</p></def></def-item><def-item><term>ECL</term><def><p id="Par10">Enhanced chemiluminescence</p></def></def-item><def-item><term>ELISA</term><def><p id="Par11">Enzyme-linked immunosorbent assay</p></def></def-item><def-item><term>ERK</term><def><p id="Par12">Extracellular signal-related kinase</p></def></def-item><def-item><term>FBS</term><def><p id="Par13">Fetal bovine serum</p></def></def-item><def-item><term>FCS</term><def><p id="Par14">Fetal calf serum</p></def></def-item><def-item><term>FID</term><def><p id="Par15">Flame ionization detector</p></def></def-item><def-item><term>GC</term><def><p id="Par16">Gas chromatography</p></def></def-item><def-item><term>IKK</term><def><p id="Par17">I&#x003ba;B kinase</p></def></def-item><def-item><term>IL</term><def><p id="Par18">Interleukin</p></def></def-item><def-item><term>iNOS</term><def><p id="Par19">Inducible nitric oxide synthase</p></def></def-item><def-item><term>JNK</term><def><p id="Par20">c-Jun <italic>N</italic>-terminal kinase</p></def></def-item><def-item><term>LPS</term><def><p id="Par21">Lipopolysaccharides</p></def></def-item><def-item><term>MAPK</term><def><p id="Par22">Mitogen-activated protein kinase</p></def></def-item><def-item><term>MS</term><def><p id="Par23">Mass spectrometry</p></def></def-item><def-item><term>NF-&#x003ba;B</term><def><p id="Par24">Nuclear factor kappa-light-chain-enhancer of activated B cells</p></def></def-item><def-item><term>NIST</term><def><p id="Par25">National Institutes of Science and Technology</p></def></def-item><def-item><term>NO</term><def><p id="Par26">Nitric oxide</p></def></def-item><def-item><term>p38</term><def><p id="Par27">p38 mitogen-activated protein kinase</p></def></def-item><def-item><term>PBS</term><def><p id="Par28">Phosphate-buffered saline</p></def></def-item><def-item><term>PKC</term><def><p id="Par29">Protein kinase C</p></def></def-item><def-item><term>PVDF</term><def><p id="Par30">Polyvinylidene fluoride</p></def></def-item><def-item><term>RIPA</term><def><p id="Par31">Radioimmunoprecipitation assay</p></def></def-item><def-item><term>ROS</term><def><p id="Par32">Reactive oxygen species</p></def></def-item><def-item><term>RPMI</term><def><p id="Par33">Roswell Park Memorial Institute</p></def></def-item><def-item><term>SD</term><def><p id="Par34">Standard deviation</p></def></def-item><def-item><term>SDS-PAGE</term><def><p id="Par35">Sodium dodecyl sulfate-polyacrylamide gel electrophoresis</p></def></def-item><def-item><term>SEAP</term><def><p id="Par36">Secreted embryonic alkaline phosphatase</p></def></def-item><def-item><term>TLC</term><def><p id="Par37">Thin-layer chromatography</p></def></def-item><def-item><term>TNF</term><def><p id="Par38">Tumor necrosis factor</p></def></def-item><def-item><term>WB</term><def><p id="Par39">Western blot</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not Applicable</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>CLH and KFH conceived and designed the experiments. CLH, LHL and YCW performed the experiment and analyzed the data. TCJ wrote the paper. LHL and KFH revised the manuscript. TCJ provided the grant and manuscript editing. All authors read and approved of the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by grants from the Ministry of Science and Technology of Taiwan (No. MOST 106&#x02013;2311-B-029-005 and No. MOST 107&#x02013;2311-B-029-002), Taiwan. These supports were for the design and execution of the experiment.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data of this study is included in the manuscript.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par67">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par68">All authors mentioned agreed for the publication of the manuscript.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par69">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S-S</given-names></name><name><surname>Huang</surname><given-names>C-G</given-names></name><name><surname>Chen</surname><given-names>Y-J</given-names></name><name><surname>Yu</surname><given-names>J-J</given-names></name><name><surname>Chen</surname><given-names>W-J</given-names></name><name><surname>Chang</surname><given-names>S-T</given-names></name></person-group><article-title>Chemical compositions and larvicidal activities of leaf essential oils from two eucalyptus species</article-title><source>Bioresour Technol</source><year>2009</year><volume>100</volume><issue>1</issue><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2008.02.038</pub-id><?supplied-pmid 18396398?><pub-id pub-id-type="pmid">18396398</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Abebe</surname><given-names>W</given-names></name><name><surname>Sousa</surname><given-names>SM</given-names></name><name><surname>Duarte</surname><given-names>VG</given-names></name><name><surname>Machado</surname><given-names>MIL</given-names></name><name><surname>Matos</surname><given-names>FJA</given-names></name></person-group><article-title>Analgesic and anti-inflammatory effects of essential oils of Eucalyptus</article-title><source>J Ethnopharmacol</source><year>2003</year><volume>89</volume><issue>2&#x02013;3</issue><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.09.007</pub-id><?supplied-pmid 14611892?><pub-id pub-id-type="pmid">14611892</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadlon</surname><given-names>AE</given-names></name><name><surname>Lamson</surname><given-names>DW</given-names></name></person-group><article-title>Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices</article-title><source>Altern Med Rev</source><year>2010</year><volume>15</volume><issue>1</issue><fpage>33</fpage><lpage>47</lpage><?supplied-pmid 20359267?><pub-id pub-id-type="pmid">20359267</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Habila N, Agbaji AS, Ladan Z, Bello IA, Haruna E, Dakare MA, Atolagbe TO. Evaluation of in vitro activity of essential oils against Trypanosoma brucei brucei and Trypanosoma evansi. J Parasitol Res. 2010;2010.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>MA</given-names></name><name><surname>de Oliveira Monteiro</surname><given-names>CM</given-names></name><name><surname>Scoralik</surname><given-names>MG</given-names></name><name><surname>Gomes</surname><given-names>FT</given-names></name><name><surname>de Azevedo Prata</surname><given-names>MC</given-names></name><name><surname>Daemon</surname><given-names>E</given-names></name></person-group><article-title>Acaricidal activity of the essential oils from Eucalyptus citriodora and Cymbopogon nardus on larvae of Amblyomma cajennense (Acari: Ixodidae) and Anocentor nitens (Acari: Ixodidae)</article-title><source>Parasitol Res</source><year>2010</year><volume>107</volume><issue>4</issue><fpage>987</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1007/s00436-010-1965-0</pub-id><?supplied-pmid 20640444?><pub-id pub-id-type="pmid">20640444</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachir</surname><given-names>RG</given-names></name><name><surname>Benali</surname><given-names>M</given-names></name></person-group><article-title>Antibacterial activity of the essential oils from the leaves of Eucalyptus globulus against Escherichia coli and Staphylococcus aureus</article-title><source>Asian Pac J Trop Biomed</source><year>2012</year><volume>2</volume><issue>9</issue><fpage>739</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60220-2</pub-id><?supplied-pmid 23570005?><pub-id pub-id-type="pmid">23570005</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>MZM</given-names></name><name><surname>Elansary</surname><given-names>HO</given-names></name><name><surname>Ali</surname><given-names>HM</given-names></name><name><surname>El-Settawy</surname><given-names>AA</given-names></name><name><surname>Elshikh</surname><given-names>MS</given-names></name><name><surname>Abdel-Salam</surname><given-names>EM</given-names></name><name><surname>Skalicka-Wozniak</surname><given-names>K</given-names></name></person-group><article-title>Bioactivity of essential oils extracted from Cupressus macrocarpa branchlets and Corymbia citriodora leaves grown in Egypt</article-title><source>BMC Complement Altern Med</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s12906-018-2085-0</pub-id><?supplied-pmid 29357851?><pub-id pub-id-type="pmid">29357851</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siramon</surname><given-names>P</given-names></name><name><surname>Ohtani</surname><given-names>Y</given-names></name></person-group><article-title>Antioxidative and antiradical activities of &#x00026;lt;i&#x00026;gt;<italic>Eucalyptus camaldulensis</italic>&#x00026;lt;/i&#x00026;gt; leaf oils from Thailand</article-title><source>J Wood Sci</source><year>2007</year><volume>53</volume><issue>6</issue><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1007/s10086-007-0887-7</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name><name><surname>Savill</surname><given-names>J</given-names></name></person-group><article-title>Resolution of inflammation: the beginning programs the end</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><issue>12</issue><fpage>1191</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1038/ni1276</pub-id><?supplied-pmid 16369558?><pub-id pub-id-type="pmid">16369558</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>P</given-names></name><name><surname>Shaik-Dasthagirisaeb</surname><given-names>Y</given-names></name></person-group><article-title>Atherosclerosis: a chronic inflammatory disease mediated by mast cells</article-title><source>Cent Eur J Immunol</source><year>2015</year><volume>40</volume><issue>3</issue><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.5114/ceji.2015.54603</pub-id><?supplied-pmid 26648785?><pub-id pub-id-type="pmid">26648785</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name></person-group><article-title>New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis</article-title><source>Redox Biol</source><year>2018</year><volume>20</volume><fpage>247</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2018.09.025</pub-id><?supplied-pmid 30384259?><pub-id pub-id-type="pmid">30384259</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bektas</surname><given-names>A</given-names></name><name><surname>Schurman</surname><given-names>SH</given-names></name><name><surname>Sen</surname><given-names>R</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name></person-group><article-title>Human T cell immunosenescence and inflammation in aging</article-title><source>J Leukoc Biol</source><year>2017</year><volume>102</volume><issue>4</issue><fpage>977</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1189/jlb.3RI0716-335R</pub-id><?supplied-pmid 28733462?><pub-id pub-id-type="pmid">28733462</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaworski</surname><given-names>T</given-names></name><name><surname>Lechat</surname><given-names>B</given-names></name><name><surname>Demedts</surname><given-names>D</given-names></name><name><surname>Gielis</surname><given-names>L</given-names></name><name><surname>Devijver</surname><given-names>H</given-names></name><name><surname>Borghgraef</surname><given-names>P</given-names></name><name><surname>Duimel</surname><given-names>H</given-names></name><name><surname>Verheyen</surname><given-names>F</given-names></name><name><surname>Kugler</surname><given-names>S</given-names></name><name><surname>Van Leuven</surname><given-names>F</given-names></name></person-group><article-title>Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration</article-title><source>Am J Pathol</source><year>2011</year><volume>179</volume><issue>4</issue><fpage>2001</fpage><lpage>2015</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.06.025</pub-id><?supplied-pmid 21839061?><pub-id pub-id-type="pmid">21839061</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>DuBois</surname><given-names>RN</given-names></name></person-group><article-title>Immunosuppression associated with chronic inflammation in the tumor microenvironment</article-title><source>Carcinogenesis</source><year>2015</year><volume>36</volume><issue>10</issue><fpage>1085</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgv123</pub-id><?supplied-pmid 26354776?><pub-id pub-id-type="pmid">26354776</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>RP</given-names></name></person-group><source>Identification of essential oil components by gas chromatography/Quadrupole mass spectroscopy</source><year>2007</year><edition>4</edition><publisher-loc>Carol Stream</publisher-loc><publisher-name>Allured</publisher-name></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>PC</given-names></name><name><surname>Chien</surname><given-names>SC</given-names></name><name><surname>Ho</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>EI</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Kuo</surname><given-names>YH</given-names></name><name><surname>Jeyashoke</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>WC</given-names></name><name><surname>Chao</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Osthole regulates inflammatory mediator expression through modulating NF-kappaB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species</article-title><source>J Agric Food Chem</source><year>2010</year><volume>58</volume><issue>19</issue><fpage>10445</fpage><lpage>10451</lpage><pub-id pub-id-type="doi">10.1021/jf102812t</pub-id><?supplied-pmid 20839800?><pub-id pub-id-type="pmid">20839800</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LH</given-names></name><name><surname>Ju</surname><given-names>TC</given-names></name><name><surname>Hsieh</surname><given-names>CY</given-names></name><name><surname>Dong</surname><given-names>WC</given-names></name><name><surname>Chen</surname><given-names>WT</given-names></name><name><surname>Hua</surname><given-names>KF</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name></person-group><article-title>A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>7</issue><fpage>e0182057</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0182057</pub-id><?supplied-pmid 28750089?><pub-id pub-id-type="pmid">28750089</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-kappaB signaling pathway</article-title><source>Food Chem</source><year>2015</year><volume>166</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.06.022</pub-id><?supplied-pmid 25053100?><pub-id pub-id-type="pmid">25053100</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>LK</given-names></name><name><surname>Liao</surname><given-names>PC</given-names></name><name><surname>Ho</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>EI</given-names></name><name><surname>Chuang</surname><given-names>CC</given-names></name><name><surname>Chiu</surname><given-names>HW</given-names></name><name><surname>Hung</surname><given-names>LB</given-names></name><name><surname>Hua</surname><given-names>KF</given-names></name></person-group><article-title>Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression</article-title><source>J Agric Food Chem</source><year>2010</year><volume>58</volume><issue>6</issue><fpage>3472</fpage><lpage>3478</lpage><pub-id pub-id-type="doi">10.1021/jf904207m</pub-id><?supplied-pmid 20192217?><pub-id pub-id-type="pmid">20192217</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeuerle</surname><given-names>PA</given-names></name></person-group><article-title>IkappaB-NF-kappaB structures: at the interface of inflammation control</article-title><source>Cell</source><year>1998</year><volume>95</volume><issue>6</issue><fpage>729</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81694-3</pub-id><?supplied-pmid 9865689?><pub-id pub-id-type="pmid">9865689</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambleton</surname><given-names>J</given-names></name><name><surname>Weinstein</surname><given-names>SL</given-names></name><name><surname>Lem</surname><given-names>L</given-names></name><name><surname>DeFranco</surname><given-names>AL</given-names></name></person-group><article-title>Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><issue>7</issue><fpage>2774</fpage><lpage>2778</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.7.2774</pub-id><?supplied-pmid 8610116?><pub-id pub-id-type="pmid">8610116</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumann</surname><given-names>RR</given-names></name><name><surname>Pfeil</surname><given-names>D</given-names></name><name><surname>Lamping</surname><given-names>N</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Scherzinger</surname><given-names>G</given-names></name><name><surname>Schlag</surname><given-names>P</given-names></name><name><surname>Karawajew</surname><given-names>L</given-names></name><name><surname>Herrmann</surname><given-names>F</given-names></name></person-group><article-title>Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14</article-title><source>Blood</source><year>1996</year><volume>87</volume><issue>7</issue><fpage>2805</fpage><lpage>2814</lpage><pub-id pub-id-type="doi">10.1182/blood.V87.7.2805.bloodjournal8772805</pub-id><?supplied-pmid 8639898?><pub-id pub-id-type="pmid">8639898</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werlen</surname><given-names>G</given-names></name><name><surname>Jacinto</surname><given-names>E</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><issue>11</issue><fpage>3101</fpage><lpage>3111</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.11.3101</pub-id><?supplied-pmid 9606192?><pub-id pub-id-type="pmid">9606192</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puente</surname><given-names>LG</given-names></name><name><surname>Stone</surname><given-names>JC</given-names></name><name><surname>Ostergaard</surname><given-names>HL</given-names></name></person-group><article-title>Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins</article-title><source>J Immunol</source><year>2000</year><volume>165</volume><issue>12</issue><fpage>6865</fpage><lpage>6871</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.165.12.6865</pub-id><?supplied-pmid 11120810?><pub-id pub-id-type="pmid">11120810</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Arendt</surname><given-names>CW</given-names></name><name><surname>Ellmeier</surname><given-names>W</given-names></name><name><surname>Schaeffer</surname><given-names>EM</given-names></name><name><surname>Sunshine</surname><given-names>MJ</given-names></name><name><surname>Gandhi</surname><given-names>L</given-names></name><name><surname>Annes</surname><given-names>J</given-names></name><name><surname>Petrzilka</surname><given-names>D</given-names></name><name><surname>Kupfer</surname><given-names>A</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><etal/></person-group><article-title>PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes</article-title><source>Nature</source><year>2000</year><volume>404</volume><issue>6776</issue><fpage>402</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/35006090</pub-id><?supplied-pmid 10746729?><pub-id pub-id-type="pmid">10746729</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juergens</surname><given-names>UR</given-names></name><name><surname>Stober</surname><given-names>M</given-names></name><name><surname>Vetter</surname><given-names>H</given-names></name></person-group><article-title>The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases</article-title><source>Eur J Med Res</source><year>1998</year><volume>3</volume><issue>12</issue><fpage>539</fpage><lpage>545</lpage><?supplied-pmid 9889172?><pub-id pub-id-type="pmid">9889172</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>MY</given-names></name><name><surname>Yeon</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Sairam</surname><given-names>V</given-names></name><name><surname>Valdiviez</surname><given-names>L</given-names></name><name><surname>You</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><article-title>Menthol, a unique urinary volatile compound, is associated with chronic inflammation in interstitial cystitis</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>10859</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-29085-3</pub-id><?supplied-pmid 30022124?><pub-id pub-id-type="pmid">30022124</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakad</surname><given-names>AK</given-names></name><name><surname>Pandey</surname><given-names>VV</given-names></name><name><surname>Beg</surname><given-names>S</given-names></name><name><surname>Rawat</surname><given-names>JM</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name></person-group><article-title>Biological, medicinal and toxicological significance of Eucalyptus leaf essential oil: a review</article-title><source>J Sci Food Agric</source><year>2018</year><volume>98</volume><issue>3</issue><fpage>833</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1002/jsfa.8600</pub-id><?supplied-pmid 28758221?><pub-id pub-id-type="pmid">28758221</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gbenou</surname><given-names>JD</given-names></name><name><surname>Ahounou</surname><given-names>JF</given-names></name><name><surname>Akakpo</surname><given-names>HB</given-names></name><name><surname>Laleye</surname><given-names>A</given-names></name><name><surname>Yayi</surname><given-names>E</given-names></name><name><surname>Gbaguidi</surname><given-names>F</given-names></name><name><surname>Baba-Moussa</surname><given-names>L</given-names></name><name><surname>Darboux</surname><given-names>R</given-names></name><name><surname>Dansou</surname><given-names>P</given-names></name><name><surname>Moudachirou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phytochemical composition of Cymbopogon citratus and Eucalyptus citriodora essential oils and their anti-inflammatory and analgesic properties on Wistar rats</article-title><source>Mol Biol Rep</source><year>2013</year><volume>40</volume><issue>2</issue><fpage>1127</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1007/s11033-012-2155-1</pub-id><?supplied-pmid 23065287?><pub-id pub-id-type="pmid">23065287</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juergens</surname><given-names>UR</given-names></name><name><surname>Stober</surname><given-names>M</given-names></name><name><surname>Vetter</surname><given-names>H</given-names></name></person-group><article-title>Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro</article-title><source>Eur J Med Res</source><year>1998</year><volume>3</volume><issue>11</issue><fpage>508</fpage><lpage>510</lpage><?supplied-pmid 9810029?><pub-id pub-id-type="pmid">9810029</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>XQ</given-names></name><name><surname>Tang</surname><given-names>FD</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Bian</surname><given-names>RL</given-names></name></person-group><article-title>Effect of Eucalyptus globulus oil on lipopolysaccharide-induced chronic bronchitis and mucin hypersecretion in rats</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2004</year><volume>29</volume><issue>2</issue><fpage>168</fpage><lpage>171</lpage><?supplied-pmid 15719688?><pub-id pub-id-type="pmid">15719688</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>PF</given-names></name><name><surname>Munari</surname><given-names>CC</given-names></name><name><surname>Nicolella</surname><given-names>HD</given-names></name><name><surname>Veneziani</surname><given-names>RC</given-names></name><name><surname>Tavares</surname><given-names>DC</given-names></name></person-group><article-title>Manool, a Salvia officinalis diterpene, induces selective cytotoxicity in cancer cells</article-title><source>Cytotechnology</source><year>2016</year><volume>68</volume><issue>5</issue><fpage>2139</fpage><lpage>2143</lpage><pub-id pub-id-type="doi">10.1007/s10616-015-9927-0</pub-id><?supplied-pmid 26547581?><pub-id pub-id-type="pmid">26547581</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laine</surname><given-names>L</given-names></name></person-group><article-title>Gastrointestinal effects of NSAIDs and coxibs</article-title><source>J Pain Symptom Manag</source><year>2003</year><volume>25</volume><issue>2 Suppl</issue><fpage>S32</fpage><lpage>S40</lpage><pub-id pub-id-type="doi">10.1016/S0885-3924(02)00629-2</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>JH</given-names></name><name><surname>Barthel</surname><given-names>JS</given-names></name><name><surname>Hosokawa</surname><given-names>MC</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name></person-group><article-title>NSAIDs: a clinical approach to the problems of gastrointestinal side-effects</article-title><source>Aliment Pharmacol Ther</source><year>1988</year><volume>2</volume><issue>Suppl 1</issue><fpage>121</fpage><lpage>129</lpage><?supplied-pmid 2979280?><pub-id pub-id-type="pmid">2979280</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheen</surname><given-names>CL</given-names></name><name><surname>MacDonald</surname><given-names>TM</given-names></name></person-group><article-title>Gastrointestinal side effects of NSAIDs - pharmacoeconomic implications</article-title><source>Expert Opin Pharmacother</source><year>2002</year><volume>3</volume><issue>3</issue><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1517/14656566.3.3.265</pub-id><?supplied-pmid 11866677?><pub-id pub-id-type="pmid">11866677</pub-id></element-citation></ref></ref-list></back></article>